Zobrazeno 1 - 10
of 10
pro vyhledávání: ''
Autor:
Kimberly L. Blackwell, Andriy Krendyukov, Nadja Hoebel, Sreekanth Gattu, Pere Gascón, Nadia Harbeck
Background Evaluation of adverse events (AEs) in pivotal registration trials and ongoing postmarketing surveillance is important for all biologics, including biosimilars. A combined analysis of two pivotal registration studies was performed to streng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0238ac036095c3a4868ed66f147fc65b
https://europepmc.org/articles/PMC5896710/
https://europepmc.org/articles/PMC5896710/
Autor:
Johanneke E.A. Portielje, Mark-David Levin, Monique M.E.M. Bos, Stefan Sleijfer, Jan C. Drooger, Agnes Jager, Joost van Rosmalen, Elisabeth M. P. Elsten, Hánah N. Rier, Albert‐Jan Ten Tije, Paul de Jong
Publikováno v:
Oncologist, 22(8), 901-909. AlphaMed Press
Background Survival of patients with human epidermal growth receptor 2 (HER2)-positive metastatic breast cancer (MBC) has improved dramatically since trastuzumab has become available, although the disease eventually progresses in most patients. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406b3a20ae4b55e94e4f7b28e1a8faf1
https://europepmc.org/articles/PMC5553959/
https://europepmc.org/articles/PMC5553959/
Autor:
Daniel Rea, Steve E. Jones, Rudi G. J. Westendorp, Anton J. M. de Craen, Christos Markopoulos, Robert Paridaens, Caroline Seynaeve, Willemien van de Water, Gerrit-Jan Liefers, Elysée T.M. Hille, Cornelis J.H. van de Velde, Annette Hasenburg, Hein Putter, Esther Bastiaannet
Publikováno v:
Oncologist, 18(1), 8-13
Oncologist, 18(1), 8-13. AlphaMed Press
Oncologist, 18(1), 8-13. AlphaMed Press
Introduction. For postmenopausal patients with hormone-sensitive breast cancer, outcome is worse with increasing age at diagnosis. The aim of this study was to assess the incidence of breast cancer recurrence (locoregional and distant), and contralat
Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment
Autor:
Erica L. Mayer, William T. Barry, Sandy Rose Truong, Ann H. Partridge, Javid Moslehi, Emily Baker
BACKGROUND Cardiotoxicity can be a complication of anthracycline- or trastuzumab-based therapy for breast cancer patients. Screening echocardiograms (ECHOs) and radionuclide ventriculograms (RVGs) are often performed before administration of these ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f76b777423c511e40d51d7e0985a12
https://europepmc.org/articles/PMC4912366/
https://europepmc.org/articles/PMC4912366/
Autor:
Michael K. Fink, Rainer J. Klement
Publikováno v:
The Oncologist
Based on the hypothesis that impaired glucose metabolism might be associated with survival outcomes independently of overt diabetes, we sought to investigate the prognostic value of routinely used glycemic parameters in a prospective study of breast
Autor:
Franck Bonnetain, Marie-Martine Padeano, Patrick Arveux, Jean-Marc Sauzedde, Hervé Tixier, Catherine Loustalot, Tienhan Sandrine Dabakuyo, Jean Cuisenier, Zeinab Hamidou, Christian Rosburger, Marc Smail, Sylvain Causeret, Jean-Philibert Combier, Patrick Chevillote, J. Fraisse, Mariette Mercier
Publikováno v:
Oncologist
Oncologist, AlphaMed Press, 2011, 16 (10), pp.1458-1468. 〈10.1634/theoncologist.2011-0085〉
Oncologist, AlphaMed Press, 2011, 16 (10), pp.1458-1468. ⟨10.1634/theoncologist.2011-0085⟩
Oncologist, AlphaMed Press, 2011, 16 (10), pp.1458-1468. 〈10.1634/theoncologist.2011-0085〉
Oncologist, AlphaMed Press, 2011, 16 (10), pp.1458-1468. ⟨10.1634/theoncologist.2011-0085⟩
Purpose. This prospective multicenter study explored different definitions of time to deterioration (TTD) in quality of life (QoL) scores, according to different cutoffs of the minimal clinically important difference (MCID) as a modality for longitud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32962cddd4fae3cffd41ddfcc09fc32e
https://europepmc.org/articles/PMC3228064/
https://europepmc.org/articles/PMC3228064/
Autor:
Melissa E. Hughes, Stephen B. Edge, Richard L. Theriault, Yu-Ning Wong, Jane C. Weeks, Douglas W. Blayney, Rebecca A. Ottesen, Joyce C. Niland
Background. The role of continued trastuzumab after progression in women with human epidermal growth factor receptor (HER)-2+ metastatic breast cancer is controversial. Controlled clinical trials that establish a benefit from continued trastuzumab ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f0eac1424750dc65e50b4d07a3e96ed
https://europepmc.org/articles/PMC3228199/
https://europepmc.org/articles/PMC3228199/
Autor:
Frances M. Palmieri, Rebecca B. McNeil, Kyle E Coppola, Xochiquetzal J. Geiger, Ann E. McCullough, Surabhi Amar, Sarah A. McLaughlin, Winston Tan, Edith A. Perez, Judy C. Boughey
Long-term outcomes and hence the role of adjuvant therapy in patients with small (≤1 cm), node-negative breast cancer remain unclear. This study's objective was to evaluate whether human epidermal growth factor receptor (HER)-2 status is an indepen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437432282a19b41befbe9625f74db392
https://europepmc.org/articles/PMC3227894/
https://europepmc.org/articles/PMC3227894/
Learning Objectives After completing this course, the reader will be able to: Describe the site-specific dysregulation of some miRNAs and explain their potential as non-invasive biomarkers for diagnosis, prognostication, or markers of treatment respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d64d5b4819cadc8437d1ce8b29a918
http://hdl.handle.net/10379/11892
http://hdl.handle.net/10379/11892
Autor:
Aliana Guerrieri-Gonzaga, Andrea Decensi, Mattia Intra, Alberto Luini, A. Goldhirsch, Davide Serrano, Marco Colleoni, Matteo Lazzeroni, Fabio Bassi, Bernardo Bonanni, Giuseppe Renne, Nicole Rotmensz, Vincenzo Bagnardi, Giovanni Ivaldi, Massimiliano Cazzaniga, Umberto Veronesi, Giuseppe Viale, Edoardo Botteri
INTRODUCTION: Diagnosis of breast ductal intraepithelial neoplasia (DIN) has increased over the last decades, but proper postsurgical treatment remains controversial. We analyzed risk factors and treatment outcome in a large series of women treated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f229e67d1880b555ce7130e04ab7715e
http://hdl.handle.net/10281/12868
http://hdl.handle.net/10281/12868